微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -106.04% | -417.27% | -4.02% | 147/157 | 0.06% | 泽璟制药 | 44.02% | 行业排名> |
| 2025-12-31 | -101.94% | -97.86% | -105.19% | 146/157 | -4.46% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-09-30 | -49.68% | -61.09% | -12.02% | 142/157 | 1.31% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-06-30 | -44.35% | -128.73% | -116.34% | 145/157 | 0.3% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-03-31 | -20.5% | -148.79% | 60.21% | 143/157 | -0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2024-12-31 | -51.52% | -48.22% | -67.06% | 142/157 | -9.62% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-09-30 | -30.84% | -47.42% | -59.05% | 145/157 | 4.28% | 百利天恒 | 181.27% | 行业排名> |
| 2024-06-30 | -19.39% | -55.74% | -135.32% | 145/157 | 2.69% | 百利天恒 | 186.1% | 行业排名> |
| 2024-03-31 | -8.24% | -16.55% | 76.29% | 139/157 | 2.35% | 百利天恒 | 186.89% | 行业排名> |
| 2023-12-31 | -34.76% | -30.87% | -66.16% | 139/157 | -1% | 百利天恒 | 188.56% | 行业排名> |
| 2023-09-30 | -20.92% | -21.84% | -68.03% | 140/157 | 2.36% | 小方制药 | 41.8% | 行业排名> |
| 2023-06-30 | -12.45% | -20.64% | -76.1% | 141/157 | 1.48% | 拓新药业 | 20.51% | 行业排名> |
| 2023-03-31 | -7.07% | -35.7% | 73.38% | 138/157 | 1.37% | 拓新药业 | 19.87% | 行业排名> |
| 2022-12-31 | -26.56% | 58.38% | -54.69% | 137/157 | 0.79% | 拓新药业 | 19.91% | 行业排名> |
| 2022-09-30 | -17.17% | 55.47% | -66.38% | 134/157 | 2.86% | 小方制药 | 55.57% | 行业排名> |
| 2022-06-30 | -10.32% | 55.95% | -98.08% | 138/157 | 2.21% | 福元医药 | 25.41% | 行业排名> |
| 2022-03-31 | -5.21% | 2% | 91.84% | 129/157 | 1.59% | 小方制药 | 34.81% | 行业排名> |
| 2021-12-31 | -63.82% | -34.64% | -65.51% | 143/157 | 0.84% | 退市金泰 | 10.74% | 行业排名> |
| 2021-09-30 | -38.56% | 2% | -64.58% | 129/157 | 4.46% | ST人福 | 6.82% | 行业排名> |
| 2021-06-30 | -23.43% | -4.88% | 50.57% | 137/157 | 2.99% | 小方制药 | 71.99% | 行业排名> |
| 2020-12-31 | -47.4% | 2% | -112.18% | 137/157 | 3.8% | 汇宇制药 | 39.25% | 行业排名> |
| 2020-06-30 | -22.34% | 2% | 2% | 126/157 | 4.28% | 汇宇制药 | 28.14% | 行业排名> |